tirzepatide approved by fda approval for Zepbound (tirzepatide) injection, the first and only obesity treatment of its kind that activates both GIP and GLP-1 hormone receptors - Eli Lilly FDA Says Shortage of GLP-1
Description
Most of the time its a processing issue

First, it tells your brain that you are full

New Year, New Me
NSAIDs and Semaglutide: Renal and Gastrointestinal Risk Assessment NSAIDs reduce kidney blood flow and can impair renal function, particularly concerning for semaglutide users already at risk for dehydration from GLP-1 side effects
Should I stop my psoriasis medications if I start GLP-1 therapy
PLoS ONE 2016,11, e0168396